Loading...
| A02626 | Pages: NA | Aug 2021 | 5370 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Pharmaceutical Pellets Market
Request Now !Pellets are free flowing units, which are filled in capsules and formed by agglomeration technique. In agglomeration techniques, fine powder is taken, which is transformed into fine granules. These pellets offer several advantages such as multiple drug delivery in a single dose, masks taste of anxious drugs and thus improve patient compliance for drug administration over other dosage forms.
In addition, pharmaceutical pellets have varied application in pharmaceutical industries such as they improve aesthetic appearance of drugs and compatible for chemically incompatible drugs.
Factors such as rise in life threatening diseases (such as coronary artery diseases, hypertension, stroke, and high cholesterol) and prevalence of chronic diseases (cancers, respiratory diseases, systemic diseases, and kidney diseases) drive the market growth. In addition, increase in healthcare infrastructure and increased patient acceptance of drugs has improved due to innovation of pharmaceutical pellets fuel the growth of the pharmaceutical pellets market.
However, high manufacturing cost and dearth of skilled professionals restrain the market. Increase in R&D in the field of pharmaceutical industry is anticipated to create new opportunities during the forecast period.
The pharmaceutical pellets market is segmented on the basis of technology, mechanism of action, and geography. By technology, it is categorized into extrusion, fluid bed granulation, dry powder layering, solution & suspension layering, spray congealing, and spray drying. By mechanism of action, the market is classified into diffusion, erosion, and osmosis. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits
List of players profiled in the report
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 PHARAMACEUTICAL PELLETS MARKET, BY TECHNOLOGY
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. EXTRUSION
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. FLUID BED GRANULATION
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. DRY POWDER LAYERING
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. SOLUTION & SUSPENSION LAYERING
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. SPRAY-CONGEALING
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.7. SPRAY DRYING
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
CHAPTER 5 PHARAMACEUTICAL PELLETS MARKET, BY MECHANISM OF ACTION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. DIFFUSION
5.2.1. Market size and forecast
5.3. EROSION
5.3.1. Market size and forecast
5.4. OSMOSIS
5.4.1. Market size and forecast
CHAPTER 6 PHARAMACEUTICAL PELLETS MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Pharamaceutical Pellets Market by Technology
6.2.5. North America Pharamaceutical Pellets Market by Mechanism of Action
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe Pharamaceutical Pellets Market by Technology
6.3.5. Europe Pharamaceutical Pellets Market by Mechanism of Action
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. China market size and forecast
6.4.3.2. Japan market size and forecast
6.4.3.3. India market size and forecast
6.4.3.4. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Pharamaceutical Pellets Market by Technology
6.4.5. Asia-Pacific Pharamaceutical Pellets Market by Mechanism of Action
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. LatinAmerica market size and forecast
6.5.3.2. Middle East market size and forecast
6.5.3.3. Africa market size and forecast
6.5.4. LAMEA Pharamaceutical Pellets Market by Technology
6.5.5. LAMEA Pharamaceutical Pellets Market by Mechanism of Action
CHAPTER 7 COMPANY PROFILES
7.1. THEXA PHARMA (P) LIMITED
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. CHEMIT.IN.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. RAINBOW HEALTH CARE PRODUCTS
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. PHARMACEUTICALS PRIVATE LIMITED
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. U.K. VET CHEM.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. NAMI PHARMA.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. ABBOTT LABORATORIES
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. AVANSCURE LIFESCIENCES PRIVATE LIMITED
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. LOGRANS PHARMA PRIVATE LIMITED
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. CONCORD DRUGS LIMITED
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
